Apple
AAPL
Cisco
CSCO
Disney
DIS
4
Qualcomm
QCOM
5
Taiwan Semiconductor
TSM
US Stock MarketDetailed Quotes
BCTX BriaCell Therapeutics
- 3.650
- -0.320-8.06%
Close Mar 31 16:00 ET
13.54MMarket Cap-0.77P/E (TTM)
3.920High3.570Low51.58KVolume3.920Open3.970Pre Close190.49KTurnover1.61%Turnover RatioLossP/E (Static)3.71MShares44.25052wk High3.76P/B11.68MFloat Cap3.00052wk Low--Dividend TTM3.20MShs Float187.050Historical High--Div YieldTTM8.82%Amplitude3.000Historical Low3.693Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
BriaCell Therapeutics Stock Forum
New Clinical Data: BriaCell's Registration Trial Results for Advanced Breast Cancer Treatment
Major Milestone: BriaCell's Breast Cancer Immunotherapy Passes Critical Safety Review in Phase 3 Trial
Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell's Phase 3 Study in Metastatic Breast Cancer
Thursday, 20th March at 8:00 am
The Data Safety Monitoring Board (DSMB) identified no safety concerns, and recommended continuation of BriaCell's pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor in metastatic breast cancer
The pivotal Phase 3 study is currently under Fast Track Designation with the Food and D...
Reported Earlier, BriaCell Prices $3.05M Public Offering Of 762,500 Common Shares At $4/Share
2 MINUTES AGO, 4:45 PM EST
VIA GLOBENEWSWIRE
Briacell Therapeutics Corp - First Patient Result Supports Bria-Ots Immunotherapy Approach
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (pres...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you do...
No comment yet